Meewan, I.; Kattoula, J.; Kattoula, J.Y.; Skinner, D.; Fajtová, P.; Giardini, M.A.; Woodworth, B.; McKerrow, J.H.; Lage de Siqueira-Neto, J.; O’Donoghue, A.J.;
et al. Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L. Pharmaceuticals 2022, 15, 744.
https://doi.org/10.3390/ph15060744
AMA Style
Meewan I, Kattoula J, Kattoula JY, Skinner D, Fajtová P, Giardini MA, Woodworth B, McKerrow JH, Lage de Siqueira-Neto J, O’Donoghue AJ,
et al. Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L. Pharmaceuticals. 2022; 15(6):744.
https://doi.org/10.3390/ph15060744
Chicago/Turabian Style
Meewan, Ittipat, Jacob Kattoula, Julius Y. Kattoula, Danielle Skinner, Pavla Fajtová, Miriam A. Giardini, Brendon Woodworth, James H. McKerrow, Jair Lage de Siqueira-Neto, Anthony J. O’Donoghue,
and et al. 2022. "Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L" Pharmaceuticals 15, no. 6: 744.
https://doi.org/10.3390/ph15060744
APA Style
Meewan, I., Kattoula, J., Kattoula, J. Y., Skinner, D., Fajtová, P., Giardini, M. A., Woodworth, B., McKerrow, J. H., Lage de Siqueira-Neto, J., O’Donoghue, A. J., & Abagyan, R.
(2022). Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L. Pharmaceuticals, 15(6), 744.
https://doi.org/10.3390/ph15060744